These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 36173715)
1. Clinical characteristics of oral chronic graft-versus-host disease according to the 2014 National Institutes of Health (USA) consensus criteria. Pengpis N; Prueksrisakul T; Chanswangphuwana C Med Oral Patol Oral Cir Bucal; 2023 Mar; 28(2):e167-e173. PubMed ID: 36173715 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic response of oral chronic graft-versus-host disease to topical corticosteroids according to the 2014 National Institutes of Health (USA) consensus criteria. Siripornkitti W; Pengpis N; Chanswangphuwana C; Prueksrisakul T Med Oral Patol Oral Cir Bucal; 2024 Mar; 29(2):e219-e226. PubMed ID: 37823294 [TBL] [Abstract][Full Text] [Related]
5. The oral manifestations of chronic graft-versus-host disease (cGVHD) in paediatric allogeneic bone marrow transplant recipients. Nicolatou-Galitis O; Kitra V; Van Vliet-Constantinidou C; Peristeri J; Goussetis E; Petropoulos D; Grafakos S J Oral Pathol Med; 2001 Mar; 30(3):148-53. PubMed ID: 11271629 [TBL] [Abstract][Full Text] [Related]
6. Oral chronic graft-versus-host disease scoring using the NIH consensus criteria. Treister NS; Stevenson K; Kim H; Woo SB; Soiffer R; Cutler C Biol Blood Marrow Transplant; 2010 Jan; 16(1):108-14. PubMed ID: 19772943 [TBL] [Abstract][Full Text] [Related]
7. Oral symptom intensity, health-related quality of life, and correlative salivary cytokines in adult survivors of hematopoietic stem cell transplantation with oral chronic graft-versus-host disease. Fall-Dickson JM; Mitchell SA; Marden S; Ramsay ES; Guadagnini JP; Wu T; St John L; Pavletic SZ; Biol Blood Marrow Transplant; 2010 Jul; 16(7):948-956. PubMed ID: 20139026 [TBL] [Abstract][Full Text] [Related]
8. Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD). Elad S; Zeevi I; Or R; Resnick IB; Dray L; Shapira MY Biol Blood Marrow Transplant; 2010 Jan; 16(1):62-9. PubMed ID: 19733252 [TBL] [Abstract][Full Text] [Related]
9. Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria. Cuvelier GDE; Nemecek ER; Wahlstrom JT; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Flower A; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savaşan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; West LJ; Pan B; Al Hamarneh YN; Halevy A; Schultz KR Blood; 2019 Jul; 134(3):304-316. PubMed ID: 31043425 [TBL] [Abstract][Full Text] [Related]
10. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival. Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria. Sato T; Ichinohe T; Kanda J; Yamashita K; Kondo T; Ishikawa T; Uchiyama T; Takaori-Kondo A Int J Hematol; 2011 Apr; 93(4):532-541. PubMed ID: 21465116 [TBL] [Abstract][Full Text] [Related]
12. Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review. Milosevic E; Babic A; Iovino L; Markovic M; Grce M; Greinix H Front Immunol; 2022; 13():1033263. PubMed ID: 36389657 [TBL] [Abstract][Full Text] [Related]
13. Oral health-related quality of life of patients with oral chronic graft-versus-host disease. Stolze J; Boor M; Hazenberg MD; Brand HS; Raber-Durlacher JE; Laheij AMGA Support Care Cancer; 2021 Nov; 29(11):6353-6360. PubMed ID: 33884507 [TBL] [Abstract][Full Text] [Related]
14. Superficial mucoceles in chronic graft-versus-host disease: a case report and review of the literature. Balasubramaniam R; Alawi F; DeRossi S Gen Dent; 2009; 57(1):82-8. PubMed ID: 19146147 [TBL] [Abstract][Full Text] [Related]
15. Incidence and Outcome of Atypical Manifestations of Chronic Graft-versus-Host Disease: Results From a Retrospective Single-Center Analysis. Doering J; Perl M; Weber D; Banas B; Schulz C; Hamer OW; Angstwurm K; Holler E; Herr W; Edinger M; Wolff D; Fante MA Transplant Cell Ther; 2023 Dec; 29(12):772.e1-772.e10. PubMed ID: 37777112 [TBL] [Abstract][Full Text] [Related]
16. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment]. Elad S; Levitt M; M Y S Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864 [TBL] [Abstract][Full Text] [Related]
17. Oral chronic graft-vs.-host disease characterization using the NIH scale. Fassil H; Bassim CW; Mays J; Edwards D; Baird K; Steinberg SM; Williams KM; Cowen EW; Mitchell SA; Hakim FT; Taylor T; Avila D; Zhang D; Grkovic L; Datiles M; Gress RE; Pavletic SZ J Dent Res; 2012 Jul; 91(7 Suppl):45S-51S. PubMed ID: 22699667 [TBL] [Abstract][Full Text] [Related]
18. Oral involvement in chronic graft versus host disease: a prospective study of 19 Brazilian patients. Pereira CM; de Almeida OP; Correa ME; Souza CA; Barjas-Castro ML Gen Dent; 2007; 55(1):48-51. PubMed ID: 17333967 [TBL] [Abstract][Full Text] [Related]